Furthermore, emphasising that the vaccination programmes across the country are functioning at full throttle, Dr. Herath elaborated that the country is meeting its vaccination targets at a steady pace. However, vaccine stocks are coming in, and the programme would continue until all Sri Lankans are fully immunised,” he noted. As per Epidemiology Unit statistics, 385,885 doses of the Covishield second jab have been rolled out, The Sunday Morning learnt. Likewise, blood samples had been obtained for a period of six weeks to assess the immunisation process and the Sinopharm vaccine had resulted in a 95% efficacy rate. Furthermore, he elaborated that the efficacy rate is highly satisfactory: 81.25% of people who were inoculated with the Sinopharm vaccine generated neutralising antibodies, which is similar to the antibodies generated within those who contract the Covid-19 virus naturally.

Source: The Nation July 24, 2021 16:52 UTC